Keywords
IL-18
glomerulonephritis
diagnostics
ramipril
Abstract
To research and deepen the understanding of the links between morphological tubular kidney lesion parameters and serum markers – neutrophil gelatinase-associated lipocalin (NGAL) and interleukin-18 (IL-18), in patients with chronic glomerulonephritis (CGN) with saved renal function, as well as to estimate therapeutic correction of identified changes using ACE inhibitor ramipril. The diagnosis of “chronic glomerulonephritis” was verified based on clinical, laboratory and morphological data. Patients were divided into 2 clinical groups: patients with CGN and arterial hypertension (AH) and without AH. We used the data of renal biopsies to analyze the indicators of tubular kidney lesion in patients with CGN. Levels of serum NGAL and IL-18 were measured by means of ELISA kits. Treatment of patients was carried out over 24 weeks using the ACE inhibitor ramipril. The average daily dose of ramipril for the entire treatment period for patients with AH was 12.8±5.6 mg, patients of the second group – without AH, were treated with ramipril at a dose of 2.5 mg. On the basis of rank correlation analysis, we demonstrated that the level of serum NGAL is directly correlated with interstitial fibrosis (r=0.65; p<0.05), serum IL-18 – with dystrophic changes in the epithelium of renal tubules (r=0.81; p<0.05).
Conclusion. Serum levels of NGAL and IL-18 are one of the most sensitive markers of tubular kidney lesion and have diagnostic efficiency up to 97%. A 24-week treatment with ACE inhibitor ramipril in patients with CGN with and without AH leads to a decrease in the levels of tubular kidney lesion markers.
References
1. Coppo R, Cattran D. The new oxford clinic-pathological classification of IgA nephropathy. Sec Biol Med Sci. 2010;1:241-8.
2. Devarajan P. The use of targeted biomarkers for chronic kidney disease. Adv Chronic Kidney Dis. 2010;17:469-79.
3. Presta P, Minutolo R. Renin-angiotensin system inhibitors reduce the progression of mesangioproliferative glomerulonephritis: 10-year follow-up. Eur J Intern Med. 2011;22:90-4.
4. Wright JT, Bakris G, Greene Т. African American study of kidney disease and hypertension study group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA. 2013;288:2421-31.
5. López-Novoa J, Rodríguez-Peña A, Ortiz A, Martínez-Salgado C, López Hernández F. Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications. Nephrology (Saint-Petersburg). 2013;17(2):9-38.
6. Okon K, Sulowicz W, Smolenski O. Interstitial, tubular and vascular factors in progression of rimary glomerulonephritis. Pol J Pathol. 2017;58(2):73-8.
7. Nickolas TL, Barasch J, Devarajan P. Biomarkers in acute and chronic kidney disease. Curr Opin Nephrol Hypertens. 2018;43(22):113-27.
8. Schmidt-Ott KM. Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury – where do we stand today? Nephrol Dial Transplant. 2011;26(3):762-4.
9. Ding H, He Y, Li K, Yang J, Li X, Lu, et al. Urinary neutrophil gelatinase-associated lipocalin is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol. 2017; 42:227-34.
10. Bolignano D, Coppolino G, Campo S. Urinary neutrophil gelatinase-associated lipocalin is associated with severity of renal disease in proteinuric patients. Nephrol Dial Transplant. 2008;23:414-6.
11. Bolignano D, Lacquaniti A, Coppolino G. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(2):44-237.
12. Huang F, Horikoshi S, Kurusu A. Urinary levels of interleukin-18 and disease activity in patients with IgA nephropathy. J Clin Lab Anal. 2011;15(1):30-4.
13. Beili S, Ni Z, Cao L, Zhou M. Serum IL-18 Is closely associated with renal tubulointerstitial injury and predicts renal prognosis in IgA Nephropathy. Mediators Inflamm. 2012;2:1-9.
14. Shimizu C, Fuijta T, Fuke Y, Ito K, Satomura A, Matsomuto K, Soma M. High circulating levels of the Interleukin-18 binding protein indicate the severity of glomerular involvement in systemic lupus erythematosus. Mod Rheumatol. 2012;22(1):73-9.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.
Copyright (c) 2020 Autors